CURRENT ISSUE Current Issue Cover
VOL 10 • NO 1 JAN/FEB 2019
IN THIS ISSUE

The Debate Over Alcohol Consumption: How Much Is Too Much?

Pamela Hallquist Viale, RN, MS, CNS, ANP

Fitness and Quality of Life Outcomes of Cancer Survivor Participants in a Community Exercise Program

Rita Musanti, PhD, APN-BC, Ying-Yu Chao, PhD, GNP-BC, and Katelyn Collins, BS, RDN

Botulinum Toxin for Side-Effect Management and Prevention of Surgical Complications in Patients Treated for Head and Neck Cancers and Esophageal Cancer

Leah Shaw, MSN, RN, AGPCNP-BC, AOCNP®, Angela F. Bazzell, DNP, RN, FNP-BC, AOCNP®, and Joyce E. Dains, DrPH, JD, RN, FNP-BC, FNAP, FAANP

Breast Implant–Associated Anaplastic Large Cell Lymphoma: What We Know

Nadia E. K. DePaola, MS, PA-C, and Heather Coggins, MS, PA-C

 
Section Seperator

TODAY'S NEWS

ERG Gene Variations and Risk of ALL in H...

Scientists have identified genetic variations in a...

2019 GU Cancers Symposium: TIVO-3: Tivoz...

The TIVO-3 trial was conducted to confirm progress...

Meta-analysis of Outcomes With Dose-Inte...

In a patient-level meta-analysis reported in The L...

Buparlisib in PI3K Pathway–Activated Rec...

In a phase II trial reported in the Journal of Cli...

2019 GU Cancers Symposium: Adjuvant Sequ...

A phase III Egyptian trial presented by Zaghloul e...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Methylnaltrexone: μ-Opioid Receptor Antagonist

The backbone of treatment for moderate to severe cancer pain is opioids...

Gemtuzumab Ozogamicin: Back Again

AML is a malignancy characterized by differentiation abnormalities...

Evidence-Based Oncology Practice

Today, oncology advanced practice providers (APP) play a critical role in providing cancer care to millions...

Abstracts from JADPRO Live 2018

The posters for the abstracts can be found at eventscribe.com/2018/posters/JADPROLIVE/home.asp...

Thank You to Our Peer Reviewers!

We would like to acknowledge everyone who completed peer reviews for JADPRO in the past year...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

2019 GU Cancers Symposium: CheckMate 650...

Some patients with metastatic prostate cancer...

2019 GU Cancers Symposium: JAVELIN Renal...

A combination of two drugs could become a new stan...

2019 GU Cancers Symposium: ARAMIS: Darol...

In the phase III ARAMIS trial reported by Fizazi e...

FDA Approves Adjuvant Pembrolizumab for ...

On February 15, the U.S. Food and Drug Administrat...

CMS Proposes Medicare Coverage With Evid...

Today, the Centers for Medicare & Medicaid Ser...

More Highlights More Highlights
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.